Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis.
Lolli F, Mazzanti B, Pazzagli M, Peroni E, Alcaro MC, Sabatino G, Lanzillo R, Brescia Morra V, Santoro L, Gasperini C, Galgani S, D'Elios MM, Zipoli V, Sotgiu S, Pugliatti M, Rovero P, Chelli M, Papini AM. Lolli F, et al. Among authors: brescia morra v. J Neuroimmunol. 2005 Oct;167(1-2):131-7. doi: 10.1016/j.jneuroim.2005.05.016. J Neuroimmunol. 2005. PMID: 16051375 Free article.
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy.
Lanzillo R, Orefice G, Quarantelli M, Rinaldi C, Prinster A, Ventrella G, Spitaleri D, Lus G, Vacca G, Carotenuto B, Salvatore E, Brunetti A, Tedeschi G, Brescia Morra V. Lanzillo R, et al. Among authors: brescia morra v. Mult Scler. 2010 Apr;16(4):450-4. doi: 10.1177/1352458509358909. Epub 2010 Feb 11. Mult Scler. 2010. PMID: 20150398 Clinical Trial.
Vitamin K cream reduces reactions at the injection site in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta - VIKING study.
Lanzillo R, Moccia M, Carotenuto A, Vacchiano V, Satelliti B, Panetta V, Brescia Morra V. Lanzillo R, et al. Among authors: brescia morra v. Mult Scler. 2015 Aug;21(9):1215-6. doi: 10.1177/1352458514562989. Epub 2015 Feb 6. Mult Scler. 2015. PMID: 25662354 Clinical Trial. No abstract available.
Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
Moccia M, Lanzillo R, Costabile T, Russo C, Carotenuto A, Sasso G, Postiglione E, De Luca Picione C, Vastola M, Maniscalco GT, Palladino R, Brescia Morra V. Moccia M, et al. Among authors: brescia morra v. J Neurol. 2015;262(4):961-7. doi: 10.1007/s00415-015-7666-y. Epub 2015 Feb 12. J Neurol. 2015. PMID: 25673130
Google Trends: new evidence for seasonality of multiple sclerosis.
Moccia M, Palladino R, Falco A, Saccà F, Lanzillo R, Brescia Morra V. Moccia M, et al. Among authors: brescia morra v. J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):1028-9. doi: 10.1136/jnnp-2016-313260. Epub 2016 Apr 15. J Neurol Neurosurg Psychiatry. 2016. PMID: 27083532 Free article. No abstract available.
The Dress: Transforming a web viral event into a scientific survey.
Moccia M, Lavorgna L, Lanzillo R, Brescia Morra V, Tedeschi G, Bonavita S. Moccia M, et al. Among authors: brescia morra v. Mult Scler Relat Disord. 2016 May;7:41-6. doi: 10.1016/j.msard.2016.03.001. Epub 2016 Mar 4. Mult Scler Relat Disord. 2016. PMID: 27237755
236 results